Kowarski syndrome

Also Known As:

Nanism due to growth hormone qualitative anomaly; Pituitary Dwarfism With Normal Immunoreactive Growth Hormone And Low Somatomedin; Pituitary dwarfism 4; Pituitary dwarfism with normal immunoreactive growth hormone

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Kowarski syndrome:

Growth Hormone (Somatotropin)IBA

11/01/2023 - "The diversity of genetic defects underlying Kowarski syndrome (KS) will provide new insights into growth hormone insensitivity. "
11/01/2023 - "Short Stature due to Bioinactive Growth Hormone (Kowarski Syndrome)."
11/01/2023 - "In contrast to children with growth hormone insensitivity, children with short stature due to BGH, known as Kowarski syndrome, exhibit an outstanding linear growth response to recombinant growth hormone therapy. "

Therapies and Procedures

1.	Therapeutics 11/01/2023 - "In contrast to children with growth hormone insensitivity, children with short stature due to BGH, known as Kowarski syndrome, exhibit an outstanding linear growth response to recombinant growth hormone therapy. "